Treatment of airway mucus hypersecretion

References

• Del Donno M., Bittesnich D., Chetta A., Olivieri D., Lopez‐Vidriero M. T. The effect of inflammation on mucociliary clearance in asthma: an overview. Chest 2000; 118: 1142–9
   PubMed Web of Science ®Google Scholar
• Houtmeyers E., Gosselink R., Gayan‐Ramirez G., Decramer M. Regulation of mucociliary clearance in health and disease. Eur Respir J 1999; 13: 1177–88
   PubMed Web of Science ®Google Scholar
• Maestrelli P., Saetta M., Mapp C. E., Fabbri L. M. Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: S76–S80
   PubMed Web of Science ®Google Scholar
• Davis P. B. Cystic fibrosis. Pediatr Rev 2001; 22: 257–64
   Google Scholar
• Prescott E., Lange P., Vestbo J. Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Respir J 1995; 8: 1333–8
   PubMed Web of Science ®Google Scholar
• Knowles M. R., Boucher R. C. Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 2002; 109: 571–7
   PubMed Web of Science ®Google Scholar
• Davies J. R., Herrmann A., Russell W., Svitacheva N., Wickström C., Carlstedt I. Respiratory tract mucins: structure and expression patterns. Novartis Foundation Symposium 248. Mucus Hypersecretion in Respiratory Disease. John Wiley & Sons, Chichester 2002; pp. 76–93
   Google Scholar
• Rogers D. F. The airway goblet cell. Int J Biochem Cell Biol 2003; 35: 1–6
   PubMed Web of Science ®Google Scholar
• Finkbeiner W. E. Physiology and pathology of tracheobronchial glands. Respir Physiol 1999; 118: 77–83
   PubMedGoogle Scholar
• Moniaux N., Escande F., Porchet N., Aubert J. P., Batra S. K. Structural organization and classification of the human mucin genes. Front Biosci 2001; 6: D1192–D1206
   PubMed Web of Science ®Google Scholar
• Dekker J., Rossen J. W., Buller H. A., Einerhand A. W. The MUC family: an obituary. Trends Biochem Sci 2002; 27: 126–31
   PubMed Web of Science ®Google Scholar
• Gum J. R., Jr., Crawley S. C., Hicks J. W., Szymkowski D. E., Kim Y. S. MUC17, a novel membrane‐tethered mucin. Biochem Biophys Res Commun 2002; 291: 466–75
   PubMed Web of Science ®Google Scholar
• Wu G. J., Wu M. W., Wang S. W., Liu Z., Qu P., Peng Q., et al. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over‐expression in prostate cancer cell lines and tissues with malignant progression. Gene 2001; 279: 17–31
   PubMed Web of Science ®Google Scholar
• Chen Y., Zhao Y. H., Kalaslavadi T. B., Hamati E., Nehrke K., Le A. D., et al. Genome‐wide search and identification of a novel gel‐forming mucin MUC19/Muc19 in glandular tissues. Am J Respir Cell Mol Biol 2004; 30: 155–65
   PubMed Web of Science ®Google Scholar
• Higuchi T., Orita T., Nakanishi S., Katsuya K., Watanabe H., Yamasaki Y., et al. Molecular cloning, genomic structure, and expression analysis of MUC20, a novel mucin protein, up‐regulated in injured kidney. J Biol Chem 2004; 279: 1968–79
   PubMed Web of Science ®Google Scholar
• Eapen S. S., Busse W. W. Asthma. Clin Allergy Immunol 2002; 16: 325–53
   Google Scholar
• Rogers D. F. Airway mucus hypersecretion in asthma: an undervalued pathology?. Curr Opin Pharmacol 2004; 241–50, 4
   Google Scholar
• Houston J. C., De Navasquez S., Trounce J. R. A clinical and pathological study of fatal cases of status asthmaticus. Thorax 1953; 8: 207–13
   PubMed Web of Science ®Google Scholar
• Dunnill M. S. The pathology of asthma with special reference to changes in the bronchial mucosa. J Clin Pathol 1960; 13: 27–33
   PubMed Web of Science ®Google Scholar
• Saetta M., Di Stefano A., Rosina C., Thiene G., Fabbri L. M. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am Rev Respir Dis 1991; 143: 138–43
   PubMed Web of Science ®Google Scholar
• Aikawa T., Shimura S., Sasaki H., Ebina M., Takishima T. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest 1992; 101: 916–21
   PubMed Web of Science ®Google Scholar
• Ordonez C. L., Khashayar R., Wong H. H., Ferrando R., Wu R., Hyde D. M., et al. Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. Am J Respir Crit Care Med 2001; 163: 517–23
   PubMed Web of Science ®Google Scholar
• National Heart Lung and Blood Institute, World Health Organisation. Global initiative for chronic obstructive lung disease. Publication number 2701. Bethesda National Institutes of Health. 2001
   Google Scholar
• Reid L. Pathology of chronic bronchitis. Lancet 1954; 266: 274–8
   PubMedGoogle Scholar
• Aikawa T., Shimura S., Sasaki H., Takishima T., Yaegashi H., Takahashi T. Morphometric analysis of intraluminal mucus in airways in chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 140: 477–82
   PubMed Web of Science ®Google Scholar
• Steiger D., Fahy J., Boushey H., Finkbeiner W. E., Basbaum C. Use of mucin antibodies and cDNA probes to quantify hypersecretion in vivo in human airways. Am J Respir Cell Mol Biol 1994; 10: 538–45
   PubMed Web of Science ®Google Scholar
• Caramori G., Di Gregorio C., Carlstedt I., Casolari P., Guzzinati I., Adcock I. M., et al. Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease. Histopathology 2004; 45: 477–84
   PubMed Web of Science ®Google Scholar
• Saetta M., Turato G., Baraldo S., Zanin A., Braccioni F., Mapp C. E., et al. Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation. Am J Respir Crit Care Med 2000; 161: 1016–21
   PubMed Web of Science ®Google Scholar
• Mullen J. B., Wright J. L., Wiggs B. R., Pare P. D., Hogg J. C. Structure of central airways in current smokers and ex‐smokers with and without mucus hypersecretion: relationship to lung function. Thorax 1987; 42: 843–8
   PubMed Web of Science ®Google Scholar
• Reid L. Measurement of the bronchial mucous gland layer: a diagnostic yardstick in chronic bronchitis. Thorax 1960; 15: 132–41
   PubMedGoogle Scholar
• Restrepo G., Heard B. E. The size of the bronchial glands in chronic bronchitis. J Pathol Bacteriol 1963; 85: 305–10
   PubMedGoogle Scholar
• Jeffery P. K. Differences and similarities between chronic obstructive pulmonary disease and asthma. Clin Exp Allergy 1999; 29 Suppl 2: 14–26
   Google Scholar
• Saetta M., Turato G., Maestrelli P., Mapp C. E., Fabbri L. M. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1304–9
   PubMed Web of Science ®Google Scholar
• Djukanovic R. Airway inflammation in asthma and its consequences: implications for treatment in children and adults. J Allergy Clin Immunol 2002; 109 Suppl 6: S539–S548
   Google Scholar
• Barnes P. J. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004; 56: 515–48
   PubMed Web of Science ®Google Scholar
• Lopez‐Vidriero M. T., Reid L. Chemical markers of mucous and serum glycoproteins and their relation to viscosity in mucoid and purulent sputum from various hypersecretory diseases. Am Rev Respir Dis 1978; 117: 465–77
   PubMed Web of Science ®Google Scholar
• Charman J., Reid L. Sputum viscosity in chronic bronchitis, bronchiectasis, asthma and cystic fibrosis. Biorheology 1972; 9: 185–99
   PubMedGoogle Scholar
• Shimura S., Sasaki T., Sasaki H., Takishima T., Umeya K. Viscoelastic properties of bronchorrhoea sputum in bronchial asthmatics. Biorheology 1988; 25: 173–9
   PubMed Web of Science ®Google Scholar
• Sheehan J. K., Richardson P. S., Fung D. C., Howard M., Thornton D. J. Analysis of respiratory mucus glycoproteins in asthma: a detailed study from a patient who died in status asthmaticus. Am J Respir Cell Mol Biol 1995; 13: 748–56
   PubMed Web of Science ®Google Scholar
• Rogers D. F., Evans T. W. Plasma exudation and oedema in asthma. Br Med Bull 1992; 48: 120–34
   PubMed Web of Science ®Google Scholar
• Shimura S., Andoh Y., Haraguchi M., Shirato K. Continuity of airway goblet cells and intraluminal mucus in the airways of patients with bronchial asthma. Eur Respir J 1996; 9: 1395–401
   PubMed Web of Science ®Google Scholar
• Thornton D. J., Carlstedt I., Howard M., Devine P. L., Price M. R., Sheehan J. K. Respiratory mucins: identification of core proteins and glycoforms. Biochem J 1996; 316: 967–75
   PubMed Web of Science ®Google Scholar
• Hovenberg H. W., Davies J. R., Herrmann A., Linden C. J., Carlstedt I. MUC5AC, but not MUC2, is a prominent mucin in respiratory secretions. Glycoconj J 1996; 13: 839–47
   PubMed Web of Science ®Google Scholar
• Wickstrom C., Davies J. R., Eriksen G. V., Veerman E. C., Carlstedt I. MUC5B is a major gel‐forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: identification of glycoforms and C‐terminal cleavage. Biochem J 1998; 334: 685–93
   PubMed Web of Science ®Google Scholar
• Sheehan J. K., Howard M., Richardson P. S., Longwill T., Thornton D. J. Physical characterization of a low‐charge glycoform of the MUC5B mucin comprising the gel‐phase of an asthmatic respiratory mucous plug. Biochem J 1999; 338: 507–13
   PubMed Web of Science ®Google Scholar
• Kirkham S., Sheehan J. K., Knight D., Richardson P. S., Thornton D. J. Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B. Biochem J 2002; 361: 537–46
   PubMed Web of Science ®Google Scholar
• Chen Y., Zhao Y. H., Di Y. P., Wu R. Characterization of human mucin 5B gene expression in airway epithelium and the genomic clone of the amino‐terminal and 5′‐flanking region. Am J Respir Cell Mol Biol 2001; 25: 542–53
   PubMed Web of Science ®Google Scholar
• Davies J. R., Carlstedt I. Respiratory tract mucins. Cilia and Mucus: from Development to Respiratory Defense., M Salthe. Marcel Dekker, Inc., New York 2001; p. 167–78, In
   Google Scholar
• Groneberg D. A., Eynott P. R., Lim S., Oates T., Wu R., Carlstedt I., et al. Expression of respiratory mucins in fatal status asthmaticus and mild asthma. Histopathology 2002; 40: 367–73
   PubMed Web of Science ®Google Scholar
• Groneberg D. A., Eynott P. R., Oates T., Lim S., Wu R., Carlstedt I., et al. Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung. Respir Med 2002; 96: 81–6
   PubMed Web of Science ®Google Scholar
• Davies J. R., Svitacheva N., Lannefors L., Kornfalt R., Carlstedt I. Identification of MUC5B, MUC5AC and small amounts of MUC2 mucins in cystic fibrosis airway secretions. Biochem J 1999; 344: 321–30
   PubMed Web of Science ®Google Scholar
• Glynn A. A., Michaels L. Bronchial biopsy in chronic bronchitis and asthma. Thorax 1960; 15: 142–53
   Google Scholar
• Houtmeyers E., Gosselink R., Gayan‐Ramirez G., Decramer M. Effects of drugs on mucus clearance. Eur Respir J 1999; 14: 452–67
   PubMed Web of Science ®Google Scholar
• Rogers D. F. The role of airway secretions in COPD: pathophysiology, epidemiology and pharmacotherapeutic options. COPD: J Chron Obstructive Pulm Dis 2005; 2: 341–53
   Google Scholar
• Rogers D. F. Mucociliary dysfunction in COPD: effect of current pharmacotherapeutic options. Pulm Pharmacol Ther 2005; 18: 1–8
   PubMed Web of Science ®Google Scholar
• Rogers D. F. Mucoactive drugs for asthma and COPD: any place in therapy?. Expert Opin Investig Drugs 2002; 11: 15–35
   PubMed Web of Science ®Google Scholar
• National Institute for Clinical Excellence (NICE). Chronic obstructive pulmonary disease: national clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004; 59((Suppl 1))1–232
   Google Scholar
• Li Y., Martin L. D., Spizz G., Adler K. B. MARCKS Protein Is a Key Molecule Regulating Mucin Secretion by Human Airway Epithelial Cells in Vitro. J Biol Chem 2001; 276: 40982–90
   PubMed Web of Science ®Google Scholar
• Singer M., Martin L. D., Vargaftig B. B., Park J., Gruber A. D., Li Y., et al. A MARCKS‐related peptide blocks mucus hypersecretion in a mouse model of asthma. Nat Med 2004; 10: 193–6
   PubMed Web of Science ®Google Scholar
• Evans C., Kheradmand F., Corry D., Tuvim M., Densmore C., Waldrep C., et al. Gene therapy of mucus hypersecretion in experimental asthma. Chest 2002; 121((3 Suppl))90S–91S
   Google Scholar
• Foster K. A. A new wrinkle on pain relief: re‐engineering clostridial neurotoxins for analgesics. Drug Discov Today 2005; 10: 563–9
   Web of Science ®Google Scholar
• Ford E., Cruttwell C., Nute E., Chaddock J., Barnes P., Sutton J., et al. Inhibition of mucin secretion from A549 cells using a re‐targeted clostridial endopeptidase. Proc Am Thor Soc 2005; 2: A219
   Google Scholar
• Burgel P. R., Nadel J. A. Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium. Thorax 2004; 59: 992–6
   PubMed Web of Science ®Google Scholar
• O'Donnell R. A., Richter A., Ward J., Angco G., Mehta A., Rousseau K., et al. Expression of ErbB receptors and mucins in the airways of long term current smokers. Thorax 2004; 59: 1032–40
   PubMed Web of Science ®Google Scholar
• Longphre M., Li D., Li J., Matovinovic E., Gallup M., Samet J. M., et al. Lung mucin production is stimulated by the air pollutant residual oil fly ash. Toxicol Appl Pharmacol 2000; 162: 86–92
   PubMed Web of Science ®Google Scholar
• Shim J. J., Dabbagh K., Takeyama K., Burgel P. R., Dao‐Pick T. P., Ueki I. F., et al. Suplatast tosilate inhibits goblet‐cell metaplasia of airway epithelium in sensitized mice. J Allergy Clin Immunol 2000; 105: 739–45
   PubMed Web of Science ®Google Scholar
• Wang B., Lim D. J., Han J., Kim Y. S., Basbaum C. B., Li J. D. Novel cytoplasmic proteins of nontypeable Haemophilus influenzae up‐regulate human MUC5AC mucin transcription via a positive p38 mitogen‐activated protein kinase pathway and a negative phosphoinositide 3‐kinase‐Akt pathway. J Biol Chem 2002; 277: 949–57
   PubMed Web of Science ®Google Scholar
• Atherton H. C., Jones G., Danahay H. IL‐13‐induced changes in the goblet cell density of human bronchial epithelial cell cultures: MAP kinase and phosphatidylinositol 3‐kinase regulation. Am J Physiol Lung Cell Mol Physiol 2003; 285: L730–L9
   PubMed Web of Science ®Google Scholar
• Zhou Y., Shapiro M., Dong Q., Louahed J., Weiss C., Wan S., et al. A calcium‐activated chloride channel blocker inhibits goblet cell metaplasia and mucus overproduction. Mucus Hypersecretion in Respiratory Disease. Wiley, Chichester 2002; p. 150–65
   Google Scholar
• Nakanishi A., Morita S., Iwashita H., Sagiya Y., Ashida Y., Shirafuji H., et al. Role of gob‐5 in mucus overproduction and airway hyperresponsiveness in asthma. Proc Natl Acad Sci U S A 2001; 98: 5175–80
   PubMed Web of Science ®Google Scholar
• Knight D. Talniflumate (Genaera). Curr Opin Investig Drugs 2004; 5: 557–62
   PubMedGoogle Scholar
• Guzman K., Gray T. E., Yoon J. H., Nettesheim P. Quantitation of mucin RNA by PCR reveals induction of both MUC2 and MUC5AC mRNA levels by retinoids. Am J Physiol 1996; 271: L1023–8
   PubMed Web of Science ®Google Scholar
• Yoon J. H., Gray T., Guzman K., Koo J. S., Nettesheim P. Regulation of the secretory phenotype of human airway epithelium by retinoic acid, triiodothyronine, and extracellular matrix. Am J Respir Cell Mol Biol 1997; 16: 724–31
   PubMed Web of Science ®Google Scholar
• Koo J. S., Jetten A. M., Belloni P., Yoon J. H., Kim Y. D., Nettesheim P. Role of retinoid receptors in the regulation of mucin gene expression by retinoic acid in human tracheobronchial epithelial cells. Biochem J 1999; 338: 351–7
   PubMed Web of Science ®Google Scholar
• Apfel C., Bauer F., Crettaz M., Forni L., Kamber M., Kaufmann F., et al. A retinoic acid receptor alpha antagonist selectively counteracts retinoic acid effects. Proc Natl Acad Sci U S A 1992; 89: 7129–33
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S. N., Manna B., Smiley R., Ashbaugh P., Coutinho R., Kaufman B. Smoke‐induced inhalation injury: effects of retinoic acid and antisense oligodeoxynucleotide on stability and differentiated state of the mucociliary epithelium. Inflammation 1998; 22: 203–14
   PubMed Web of Science ®Google Scholar
• Tesfaigzi Y., Fischer M. J., Martin A. J., Seagrave J. Bcl‐2 in LPS‐ and allergen‐induced hyperplastic mucous cells in airway epithelia of Brown Norway rats. Am J Physiol Lung Cell Mol Physiol 2000; 279: L1210–17
   PubMed Web of Science ®Google Scholar
• Kellerman D. J. P2Y(2) receptor agonists: a new class of medication targeted at improved mucociliary clearance. Chest 2002; 121((5 Suppl))201S–05S
   Google Scholar
• Roger P., Gascard J. P., Bara J., de Montpreville V. T., Yeadon M., Brink C. ATP induced MUC5AC release from human airways in vitro. Mediators Inflamm 2000; 9: 277–84
   PubMed Web of Science ®Google Scholar
• Jackson A. D. Airway goblet‐cell mucus secretion. Trends Pharmacol Sci 2001; 22: 39–45
   PubMed Web of Science ®Google Scholar